Shanqiang Qu

704 total citations
34 papers, 499 citations indexed

About

Shanqiang Qu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Shanqiang Qu has authored 34 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Shanqiang Qu's work include Ferroptosis and cancer prognosis (13 papers), Glioma Diagnosis and Treatment (9 papers) and RNA modifications and cancer (7 papers). Shanqiang Qu is often cited by papers focused on Ferroptosis and cancer prognosis (13 papers), Glioma Diagnosis and Treatment (9 papers) and RNA modifications and cancer (7 papers). Shanqiang Qu collaborates with scholars based in China and United States. Shanqiang Qu's co-authors include Zhicheng Hu, Jin Liu, Huafu Wang, Shuting Li, Bing Tang, Jiayuan Zhu, Songtao Qi, Guozhong Yi, Rongyang Xu and Guanglong Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Journal of Investigative Dermatology.

In The Last Decade

Shanqiang Qu

30 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shanqiang Qu China 17 235 123 108 82 77 34 499
Sonja Gustafsson Sweden 5 284 1.2× 58 0.5× 76 0.7× 109 1.3× 52 0.7× 5 515
Lydia Greenlees United States 10 268 1.1× 48 0.4× 113 1.0× 69 0.8× 28 0.4× 16 480
Hope Mumme United States 8 260 1.1× 36 0.3× 62 0.6× 40 0.5× 47 0.6× 15 522
P Houston United Kingdom 9 273 1.2× 51 0.4× 93 0.9× 42 0.5× 26 0.3× 16 591
Jon M. Carthy Canada 12 296 1.3× 90 0.7× 89 0.8× 102 1.2× 15 0.2× 20 598
Julian Nüchel Germany 12 304 1.3× 46 0.4× 67 0.6× 24 0.3× 22 0.3× 14 634
Mengzhu Lv China 11 161 0.7× 47 0.4× 104 1.0× 74 0.9× 38 0.5× 23 364
Carine Strup-Perrot France 12 160 0.7× 72 0.6× 55 0.5× 91 1.1× 110 1.4× 14 441
Sooyeon Lee Germany 11 262 1.1× 33 0.3× 101 0.9× 120 1.5× 86 1.1× 17 647
Muthurangan Manikandan Saudi Arabia 17 407 1.7× 47 0.4× 169 1.6× 136 1.7× 143 1.9× 38 738

Countries citing papers authored by Shanqiang Qu

Since Specialization
Citations

This map shows the geographic impact of Shanqiang Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanqiang Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanqiang Qu more than expected).

Fields of papers citing papers by Shanqiang Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanqiang Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanqiang Qu. The network helps show where Shanqiang Qu may publish in the future.

Co-authorship network of co-authors of Shanqiang Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Shanqiang Qu. A scholar is included among the top collaborators of Shanqiang Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanqiang Qu. Shanqiang Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yi, Guozhong, et al.. (2025). Identification of the clinical and genetic characteristics of gliomas with gene fusions by integrated genomic and transcriptomic analysis. European journal of medical research. 30(1). 49–49. 1 indexed citations
2.
Qu, Shanqiang, et al.. (2025). The HBP Pathway Inhibitor FR054 Enhances Temozolomide Sensitivity in Glioblastoma Cells by Promoting Ferroptosis and Inhibiting O‐GlcNAcylation. CNS Neuroscience & Therapeutics. 31(8). e70546–e70546. 1 indexed citations
3.
Qu, Shanqiang, Zhi Ye, Qiuming Pan, et al.. (2025). Contemporary Precision Stratification and Prognostic Features of Primary Gliomas in a Southern Chinese Population. Research. 8. 1014–1014.
4.
Pan, Qiuming, Zhi Ting Ye, Junxi Wang, et al.. (2025). Unveiling the complexity of cellular senescence in cancers: From mechanism to therapeutic opportunities. SHILAP Revista de lepidopterología. 3(3). 1 indexed citations
5.
Wang, Luyao, Ye Zhu, Qiuming Pan, et al.. (2025). Targeting ferroptosis in cancer stem cells: A novel strategy to improve cancer treatment. Genes & Diseases. 12(6). 101678–101678. 3 indexed citations
6.
Yang, Hao, Dongming Lv, Shanqiang Qu, et al.. (2024). A ROS‐Responsive Lipid Nanoparticles Release Multifunctional Hydrogel Based on Microenvironment Regulation Promotes Infected Diabetic Wound Healing. Advanced Science. 11(43). e2403219–e2403219. 37 indexed citations
7.
Qu, Shanqiang, Rongyang Xu, Guozhong Yi, et al.. (2024). Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine. Molecular Biomedicine. 5(1). 6–6. 34 indexed citations
8.
Wang, Luyao, et al.. (2023). The antiferroptotic role of TRIM7: Molecular mechanism and synergistic effect with temozolomide. SHILAP Revista de lepidopterología. 2(4). 237–239. 3 indexed citations
9.
Qu, Shanqiang, Kaicheng Wang, Luyao Wang, et al.. (2023). OLFML3, as a potential predictor of prognosis and therapeutic target for glioma, is closely related to immune cell infiltration. SHILAP Revista de lepidopterología. 4(2). 16 indexed citations
10.
Qu, Shanqiang, Songtao Qi, Zhiyong Li, et al.. (2023). Albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis. Journal of Experimental & Clinical Cancer Research. 42(1). 285–285. 20 indexed citations
11.
Qu, Shanqiang, et al.. (2023). The PODNL1/AKT/β-catenin signaling axis mediates glioma progression and sensitivity to temozolomide. Fundamental Research. 5(4). 1822–1830.
12.
Xu, Rongyang, Luyao Wang, & Shanqiang Qu. (2023). A novel mechanism of ferroptosis surveillance offers promising therapeutic avenues for breast and prostate cancers. Molecular Biomedicine. 4(1). 30–30. 4 indexed citations
13.
Qu, Shanqiang, Jin Liu, & Huafu Wang. (2021). EVA1B to Evaluate the Tumor Immune Microenvironment and Clinical Prognosis in Glioma. Frontiers in Immunology. 12. 648416–648416. 22 indexed citations
14.
15.
Qu, Shanqiang, Zhicheng Hu, Yi Zhang, et al.. (2021). Clinical Studies on Platelet-Rich Plasma Therapy for Chronic Cutaneous Ulcers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Advances in Wound Care. 11(2). 56–69. 13 indexed citations
16.
Qu, Shanqiang, et al.. (2020). Effect of Piezo1 Overexpression on Peritumoral Brain Edema in Glioblastomas. American Journal of Neuroradiology. 41(8). 1423–1429. 41 indexed citations
17.
Qu, Shanqiang. (2020). Clinical Significance of Molecular Biomarkers on Brain Gliomas. 2(5). 1 indexed citations
18.
Hu, Zhicheng, Shanqiang Qu, Jian Zhang, et al.. (2019). Efficacy and Safety of Platelet-Rich Plasma for Patients with Diabetic Ulcers: A Systematic Review and Meta-analysis. Advances in Wound Care. 8(7). 298–308. 36 indexed citations
19.
Hu, Zhicheng, Peng Liu, Jiän Zhang, et al.. (2017). TIEG1 Represses Smad7-Mediated Activation of TGF-β1/Smad Signaling in Keloid Pathogenesis. Journal of Investigative Dermatology. 137(5). 1051–1059. 42 indexed citations
20.
Cao, Xiaoling, Zhicheng Hu, Da Ma, et al.. (2017). Pleiotropic FTY720 Is a Specific and Potent Therapy for Hypertrophic Scars. Journal of Investigative Dermatology. 137(7). 1552–1561. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026